Department of Oncology
School of Medicine Queen's University

Program Overview

Year One

The first year of the training program consists of core oncology rotations including:

  • Medical Oncology
  • Hematology (2 blocks)
  • Radiation Oncology (2 blocks)
  • Palliative Care (1 block)

The majority of the clinical experience in medical oncology takes place in the outpatient setting. Residents are assigned to tumour specific sites and spend 2-3 month rotations attending and participating in these clinics during the first year. Residents are also involved in providing in-patient consultation services according to the site-specific rotation. 

Year Two

The second year of training includes:

  • NCIC CTG Statistical and Operations 
  • Medical Oncology
  • In-patient rotations (2 blocks)
  • Research and other electives (up to 6 blocks)

During the in-patient rotations, the resident acts as a Junior Consultant on the ward working with internal medicine house staff and with attending staff back up.

The scheduled rotations provide the trainee with the opportunity to gain experience in all aspects of the practice of medical oncology and to interact with complimentary disciples including radiation, hematology, gynecology and surgical oncology, ENT, infectious disease and palliative care. The close affiliation and good working relationship with the host hospital ensures interaction and collaboration with internal medicine, surgical and radiology specialties.

Year Three

For residents interested in additional training, Queen’s University also offers a Clinical Investigator Program (CIP).  This program offers integrated clinical and research training and the opportunity to earn a graduate degree while completing residency.  For more information, please visit

NCIC CTG Statistical and Operations Office Rotation - NEW

The NCIC Clinical Trials Group is a cooperative oncology group which carries out clinical trials in cancer therapy, supportive care and prevention across Canada and internationally. It is one of the national programmes and networks of the Canadian Cancer Society Research Institute (CCSRI), and is supported by the Canadian Cancer Society (CCS).

The NCIC CTG has two main areas of study: investigational new drugs; and comparative randomized (phase III) trials. The NCIC CTG's role in investigational new drug trials is to provide a centralized focus of knowledge, expertise, and experience to help Canadian investigators compete successfully for access to promising and scientifically interesting new agents. The Phase III program develops and conducts randomized trials across the spectrum of adult malignancies.

The main objective of the rotation for residents is to be exposed to the operational aspects of study conduct from an Investigator perspective including but not restricted to:

  1. Safety oversight
  2. Regulatory oversight, quality assurance/monitoring
  3. Protocol development and conduct
  4. Ethics & compliance principles including consent document generation
  5. Data Management; data compilation, checking, and analysis

This experience will provide exposure to the knowledge and skill base required for a clinical trialist to meaningfully participate in clinical studies in oncology, and will complement other activities such as the biennial NCIC CTG  New Investigator Clinical Trials Course and the NCIC CTG Annual Spring Meeting of Participants